Filing Details

Accession Number:
0000874015-24-000194
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2024-09-04 20:42:24
Reporting Period:
2024-02-02
Accepted Time:
2024-09-04 20:42:24
Original Submission Date:
2024-02-02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1799355 Onaiza Cadoret-Manier 2855 Gazelle Court
C/O Ionis Pharmaceuticals, Inc.
Carlsbad CA 92010
Evp,Chf Gl Pdt Str & Oper Ofc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-02-02 2,162 $49.60 35,788 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The original Form 4 filed on February 2, 2024 reported 2,125 restricted stock units sold by the reporting person which has been revised by this amendment to reflectthe actual amount of shares sold and beneficially owned by Ms. Cadoret-Manier.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.60 to $49.62 inclusive. Thereporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and ExchangeCommission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.